Treatment of patients who have severe mitral regurgitation (MR) and tricuspid regurgitation (TR) is surgical repair or replacement. However, it becomes a therapeutic challenge in patients who are at prohibitive surgical risk. In such patients, percutaneous edge-to-edge repair of mitral valve with the MitraClip system (Abbott Vascular, Santa Clara, CA, USA) has demonstrated its clinical efficacy and safety. For the tricuspid valve, various percutaneous techniques are emerging rapidly.1 We report a patient in cardiogenic shock from severe MR and TR who underwent percutaneous repair of both valves using the MitraClip system. This is the first successful percutaneous intervention of the tricuspid valve in Singapore.
This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.
